7 results on '"Tronche, François"'
Search Results
2. SWI/SNF chromatin remodeler complex within the reward pathway is required for behavioral adaptations to stress.
- Author
-
Zayed, Abdallah, Baranowski, Camille, Compagnion, Anne-Claire, Vernochet, Cécile, Karaki, Samah, Cuttoli, Romain Durand-de, Saint-Jour, Estefani, Bhattacharya, Soumee, Marti, Fabio, Vanhoutte, Peter, Yaniv, Moshe, Faure, Philippe, Barik, Jacques, Amar, Laurence, Tronche, François, and Parnaudeau, Sébastien
- Subjects
REWARD (Psychology) ,CHROMATIN ,SOCIAL defeat ,GENE silencing ,GENE expression ,DOPAMINERGIC neurons - Abstract
Enduring behavioral changes upon stress exposure involve changes in gene expression sustained by epigenetic modifications in brain circuits, including the mesocorticolimbic pathway. Brahma (BRM) and Brahma Related Gene 1 (BRG1) are ATPase subunits of the SWI/SNF complexes involved in chromatin remodeling, a process essential to enduring plastic changes in gene expression. Here, we show that in mice, social defeat induces changes in BRG1 nuclear distribution. The inactivation of the Brg1/Smarca4 gene within dopamine-innervated regions or the constitutive inactivation of the Brm/Smarca2 gene leads to resilience to repeated social defeat and decreases the behavioral responses to cocaine without impacting midbrain dopamine neurons activity. Within striatal medium spiny neurons, Brg1 gene inactivation reduces the expression of stress- and cocaine-induced immediate early genes, increases levels of heterochromatin and at a global scale decreases chromatin accessibility. Altogether these data demonstrate the pivotal function of SWI/SNF complexes in behavioral and transcriptional adaptations to salient environmental challenges. Repeated exposure to social stressors in rodents results in behavioural changes. Here the authors show that behavioural adaptations to stress are associated with nuclear organization changes through SWI/SNF chromatin remodeler in specific neuronal populations of the mesolimbic system. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells.
- Author
-
Hasni Ebou, Moina, Singh-Estivalet, Amrit, Launay, Jean-Marie, Callebert, Jacques, Tronche, François, Ferré, Pascal, Gautier, Jean-François, Guillemain, Ghislaine, Bréant, Bernadette, Blondeau, Bertrand, and Riveline, Jean-Pierre
- Subjects
GLUCOCORTICOIDS ,SEROTONIN ,PANCREATIC beta cells ,DIABETES ,INSULIN resistance ,HORMONES - Abstract
Diabetes is a major complication of chronic Glucocorticoids (GCs) treatment. GCs induce insulin resistance and also inhibit insulin secretion from pancreatic beta cells. Yet, a full understanding of this negative regulation remains to be deciphered. In the present study, we investigated whether GCs could inhibit serotonin synthesis in beta cell since this neurotransmitter has been shown to be involved in the regulation of insulin secretion. To this aim, serotonin synthesis was evaluated in vitro after treatment with GCs of either islets from CD1 mice or MIN6 cells, a beta-cell line. We also explored the effect of GCs on the stimulation of serotonin synthesis by several hormones such as prolactin and GLP 1. We finally studied this regulation in islet in two in vivo models: mice treated with GCs and with liraglutide, a GLP1 analog, and mice deleted for the glucocorticoid receptor in the pancreas. We showed in isolated islets and MIN6 cells that GCs decreased expression and activity of the two key enzymes of serotonin synthesis, Tryptophan Hydroxylase 1 (Tph1) and 2 (Tph2), leading to reduced serotonin contents. GCs also blocked the induction of serotonin synthesis by prolactin or by a previously unknown serotonin activator, the GLP-1 analog exendin-4. In vivo, activation of the Glucagon-like-Peptide-1 receptor with liraglutide during 4 weeks increased islet serotonin contents and GCs treatment prevented this increase. Finally, islets from mice deleted for the GR in the pancreas displayed an increased expression of Tph1 and Tph2 and a strong increased serotonin content per islet. In conclusion, our results demonstrate an original inhibition of serotonin synthesis by GCs, both in basal condition and after stimulation by prolactin or activators of the GLP-1 receptor. This regulation may contribute to the deleterious effects of GCs on beta cells. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. A versatile system for the neuronal subtype specific expression of lentiviral vectors.
- Author
-
Tolu, Stefania, Avale, M. Elena, Nakatani, Hiroko, Pons, Stéphanie, Parnaudeau, Sébastien, Tronche, François, Vogt, Angelika, Monyer, Hannah, Vogel, Roland, De Chaumont, Fabrice, Olivo-Marin, Jean-Christophe, Changeux, Jean-Pierre, and Maskos, Uwe
- Subjects
GENE therapy ,GENE expression ,BRAIN ,NEURONS ,MAMMALS - Abstract
Lentiviral expression vectors are powerful tools for gene therapy and long-term gene expression/ repression in the mammalian brain. However, no specificity of transduction has been reported so far in the central nervous system. Here we have developed a novel system to achieve a neuronal subtype specific expression in either dopaminergic (DA) or GABAergic neurons. We employed a delivery strategy by which the transgene is not expressed until its activation by Cre recombinase. We successfully tested the system in vitro and then used this novel lentivector, containing loxP sites, in 2 different transgenic mouse lines expressing Cre either in DA or in GABAergic neurons. In both lines the reporter gene was detected exclusively in Cre-positive cells, demonstrating that with this experimental approach we were able to achieve completely specific expression of transgenes delivered by lentiviral vectors. This universal system can be applied to all neural subtypes making use of the growing number of specific Cre driver lines. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
5. Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block.
- Author
-
Sainte-Marie, Yannis, Aurelie Nguyen Dinh Cat, Perrier, Romain, Mangin, Laurence, Soukaseum, Christelle, Peuchmaur, Michel, Tronche, François, Farman, Nicolette, Escoubet, Brigitte, Benitah, Jean-Pierre, and Jaisser, Frederic
- Subjects
GENE expression ,GLUCOCORTICOID receptors ,HEART ,ADRENOCORTICAL hormones ,ION channels - Abstract
Corticosteroid hormones (aldosterone and glucocorticoids) and their receptors are now recognized as major modulators of cardiovascular pathophysiology, but their specific roles remain elusive. Glucocorticoid hormones (GCs), which are widely used to treat acute and chronic diseases, often have adverse cardiovascular effects such as heart failure, hypertension, atherosclerosis, or metabolic alteratious. The direct effects of GC on the heart are difficult to evaluate, as changes in plasma GC concentrations have multiple consequences due to the ubiquitous expression of the glucocorticoid receptor (GR), resulting in secondary effects on cardiac function. We evaluated the effects of GR on the heart in a conditional mouse model in which the GR was overexpressed solely in cardiomyocytes. The transgenic mice displayed electrocardiogram (ECG) abnormalities: a long PQ interval, increased QRS and QTc duration as well as chronic atrio-ventricular block, without cardiac hypertrophy or fibrosis. The ECG alterations were reversible on GR expression shutoff. Isolated ventricular cardiomyocytes showed major ion channel remodeling, with decreases in I
Na , Ito , and IKslow activity and changes in cell calcium homeostasis (increase in Cal , in Ca2+ transients and in sarcoplasmic reticulum Ca2+ load). This phenotype differs from that observed in mice overexpressing the mineralocorticoid receptor in the heart, which displayed ventricular arrhythmia. Our mouse model highlights novel effects of GR activation in the heart indicating that GR has direct and specific cardiac effects in the mouse. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
6. Analysis of dopamine transporter gene expression pattern − generation of DAT-iCre transgenic mice.
- Author
-
Turiault, Marc, Parnaudeau, Sébastien, Milet, Aude, Parlato, Rosanna, Rouzeau, Jean-Denis, Lazar, Monique, and Tronche, François
- Subjects
GENE expression ,DOPAMINE ,TRANSGENIC mice ,SYNAPSES ,CHROMOSOMES ,NEURONS - Abstract
The dopamine transporter is an essential component of the dopaminergic synapse. It is located in the presynaptic neurons and regulates extracellular dopamine levels. We generated a transgenic mouse line expressing the Cre recombinase under the control of the regulatory elements of the dopamine transporter gene, for investigations of gene function in dopaminergic neurons. The codon-improved Cre recombinase ( iCre) gene was inserted into the dopamine transporter gene on a bacterial artificial chromosome. The pattern of expression of the bacterial artificial chromosome–dopamine transporter–iCre transgene was similar to that of the endogenous dopamine transporter gene, as shown by immunohistochemistry. Recombinase activity was further studied in mice carrying both the bacterial artificial chromosome–dopamine transporter–iCre transgene and a construct expressing the β-galactosidase gene after Cre-mediated recombination. In situ studies showed that β-galactosidase (5-bromo-4-chloroindol-3-yl β-d-galactoside staining) and the dopamine transporter (immunofluorescence) had identical distributions in the ventral midbrain. We used this animal model to study the distribution of dopamine transporter gene expression in hypothalamic nuclei in detail. The expression profile of tyrosine hydroxylase (an enzyme required for dopamine synthesis) was broader than that of β-galactosidase in A12 to A15. Thus, only a fraction of neurons synthesizing dopamine expressed the dopamine transporter gene. The bacterial artificial chromosome–dopamine transporter–iCre transgenic line is a unique tool for targeting Cre/ loxP-mediated DNA recombination to dopamine neurons for studies of gene function or for labeling living cells, following the crossing of these mice with transgenic Cre reporter lines producing fluorescent proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
7. Glucocorticoid hormones inhibit food‐induced phase‐shifting of peripheral circadian oscillators.
- Author
-
Le Minh, Nguyet, Damiola, Francesca, Tronche, François, Schütz, Günther, and Schibler, Ueli
- Subjects
SUPRACHIASMATIC nucleus ,GLUCOCORTICOIDS ,CLOCKS & watches ,CIRCADIAN rhythms ,GENE expression ,HORMONES - Abstract
The circadian timing system in mammals is composed of a master pacemaker in the suprachiasmatic nucleus (SCN) of the hypothalamus and slave clocks in most peripheral cell types. The phase of peripheral clocks can be completely uncoupled from the SCN pacemaker by restricted feeding. Thus, feeding time, while not affecting the phase of the SCN pacemaker, is a dominant Zeitgeber for peripheral circadian oscillators. Here we show that the phase resetting in peripheral clocks of nocturnal mice is slow when feeding time is changed from night to day and rapid when switched back from day to night. Unexpectedly, the inertia in daytime feeding‐induced phase resetting of circadian gene expression in liver and kidney is not an intrinsic property of peripheral oscillators, but is caused by glucocorticoid signaling. Thus, glucocorticoid hormones inhibit the uncoupling of peripheral and central circadian oscillators by altered feeding time. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.